With further improvements in instrumentation and column design, supercritical fluid chromatography (SFC) Is becoming a mainstream technology.
With further improvements in instrumentation and column design, supercritical fluid chromatography (SFC) Is becoming a mainstream technology. Participants in this forum are Martin Vollmer, Agilent Technologies and Harbacksh Sidhu, Waters Corporation.
What application areas do you think SFC users have not yet fully tapped into?
Vollmer: In the achiral world I see especially classical normal-phase application as a target for SFC. SFC is much faster than normal-phase chromatography, the methods are more robust, and SFC is a green technology that avoids highly toxic and expensive solvents. In addition, the analyte polarity range that can be covered is much broader than with classical normal-phase separations. SFC is also an excellent technology to deal with pesticides, lipids, polymers and polymer additives and fat soluble vitamins. For some of those compounds it is necessary to use gas chromatography (GC) and liquid chromatography (LC) to cover the complete analyte range. SFC has the potential to cover all of the compounds in a single assay. For chiral separation there is still potential to replace current LC-based chiral methods since SFC usually provides a shorter analysis time and superior selectivity.
Sidhu: In the early to mid 2000s, preparative SFC started to carve out a niche in the pharmaceutical industry as the ”go to” technique for chiral separations. Analytical-scale SFC instrumentation was barely adequate to deliver results in support of purification; thereby, it was relegated to a “qualitative” niche function. Prior to technological advances and new instrumentation, SFC was not recognized as an accepted technology, but leading chromatographers recognized its potential in the pharmaceutical industry and beyond evidenced by their publications using SFC in diverse and wide-ranging application areas. Consequently, SFC did not gain traction despite having potential advantages over current techniques. Recent advances in instrumentation and columns along with an array of available detection options such as UV, evaporative light scattering (ELS) and mass spectrometry (MS) with mature chromatography data systems enable SFC to surpass LC and GC technologies in demonstrated and future application areas. SFC technology’s advantages exceed long-accepted benefits of increased speed, separations quality, and solvent reduction. The technique is compatible with sample handling and overall workflow employed for small molecules in the pharmaceutical, food and chemical industries. The problem-solving and time-to-result capabilities extend to broad application areas in small molecule space.
How is the adoption of SFC influencing the way that new chiral separation methods are being developed?
Vollmer: SFC in general is able to cope with the same chiral columns used in LC. However, it is difficult to predict which column and solvent combination delivers the best result. Highly professional automated method development with the corresponding hardware, clever and flexible valving concepts for column and solvent selection, and intuitive software tools for method setup and data analysis are key to provide ease of use in SFC method development. This avoids unnecessary trial-and-error approaches and will increase lab productivity. I see a very high potential in SFC–ultrahigh-pressure liquid chromatography (UHPLC) hybrid method development systems since it is often not clear whether LC or SFC provides the better resolution. Automated Method development using both LC and SFC in a single system will speed up the time to develop the most suitable method for a given analyte mix significantly.
Sidhu: SFC should be the first choice for chiral separations, due to its high success rate and compatibility with chiral stationary phases. It is also a more rugged and stable separation technique than normal-phase chromatogrpahy. Chiral separations require column screening for optimal method development. SFC excels in this respect by delivering separation speed, equilibration, and resolution along with significant solvent reduction compared to normal-phase chromatography.
What kind of developments do you see on the horizon for SFC?
Vollmer: First, seamless interfacing with non-UV detectors such as MS and ELS will become more important in combination with SFC. They bear the advantage that they do not suffer from refractive index effects and changes in pressure and temperature do not affect sensitivity dramatically. In addition compounds without a chromophore are covered by MS and ELS detection. High-end MS systems such as triple quadrupole (QQQ), time-of-flight (TOF), and quadrupole TOF hyphenated to SFC will become more relevant in the future, enabling higher sensitivities and unbiased compound and impurity identification with SFC.
Second, small particle technology and small internal diameter columns can speed up chiral and achiral analysis and sample throughput even further since SFC can be conducted 2–3 times faster than LC without losing separation efficiency. This will require optimized instruments to minimize extracolumn volume and respective chiral column technology.
Third, instrumentation that provides further flexibility to conduct orthogonal method development with LC and SFC on a single instrument will expand capabilities and ensure investment protection if analytical requirements are changing.
Fourth, hopefully the development of column technology for chiral and achiral separations will lead to more universal stationary phases, which should reduce the number of different columns that need to be screened to find out the best separation conditions.
Sidhu: SFC will follow a trend comparable to HPLC. HPLC performance advances were realized with the use of sub-2-µm particle packed columns. HPLC had plateaued prior to sub-2-µm particles, and significant advances were made after their adoption. As a result of better mass transfer, increased speed and productivity is already inherent in SFC. Sub-2-µm particles will deliver even greater benefits to SFC, now that instrument challenges are overcome. We will see higher pressure range analytical systems to further enhance SFC’s capability for more applications using sub-2-µm particles. SFC has demonstrated use over a wide polarity range; CO2-only separations with density programming enable the use of flame ionization detection for universal detection of nonpolar compounds, and alcohol-modified CO2 can be used for separation of more polar species. Advances in SFC-specific column chemistries will enable more universal use and acceptance of the technology. Continued instrument and column development along with expanding application knowledge will elevate SFC as a mainstream technology in this decade.
LC–MS/MS Quantification of Plasma Proteins in Elephant Seals to Advance Wildlife Conservation
November 12th 2024Liquid chromatography and tandem mass spectrometry (LC–MS/MS) was used to show that repeated stress can cause delayed but sustained changes in blood plasma proteins associated with water conservation, immune responses, fat metabolism, insulin sensitivity, iron recycling, and hormone transport in elephant seals. Some of these changes may be novel markers of recent and chronic stress exposure in marine mammals.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Exploring The Chemical Subspace of RPLC: A Data-driven Approach
November 11th 2024Saer Samanipour from the Van ‘t Hoff Institute for Molecular Sciences (HIMS) at the University of Amsterdam spoke to LCGC International about the benefits of a data-driven reversed-phase liquid chromatography (RPLC) approach his team developed.